MedTrace Logo

Scalable Communication Modalities for Returning Genetic Research Results

NCT04407611 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 926

Last updated 2026-04-01

No results posted yet for this study

Summary

Efforts to examine the utility of alternate modalities for genetic results disclosure has widespread implications for how precision medicine research might yield direct health benefits for study participants. This study will examine the efficacy of an online self-guided program to return genetic results to a racial minority cohort population. Study results will provide empirical evidence on the effectiveness of alternate modalities for genetic results return, inform ongoing efforts to establish scalable approaches for effective return of genetic research results, and increase access to personal health information among African American women.

Conditions

Interventions

BEHAVIORAL

Online modality

Return of BRCA results directly online or return of printed BRCA results if participant cannot access online or chooses not to

BEHAVIORAL

Genetic counselor follow-up

Optional genetic counselor follow-up over the telephone

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • MGH Institute of Health Professions

    collaborator OTHER

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Boston University

    lead OTHER

Principal Investigators

  • Catharine Wang, PhD · BU School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-06
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407611 on ClinicalTrials.gov